222 related articles for article (PubMed ID: 34066964)
1. Computational Design of Novel Allosteric Inhibitors for
Shehzad S; Pandey R; Malhotra P; Gupta D
Molecules; 2021 May; 26(9):. PubMed ID: 34066964
[TBL] [Abstract][Full Text] [Related]
2. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.
Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA
J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475
[TBL] [Abstract][Full Text] [Related]
3. A secretory multifunctional serine protease, DegP of Plasmodium falciparum, plays an important role in thermo-oxidative stress, parasite growth and development.
Sharma S; Jadli M; Singh A; Arora K; Malhotra P
FEBS J; 2014 Mar; 281(6):1679-99. PubMed ID: 24494818
[TBL] [Abstract][Full Text] [Related]
4. Identification of Selective Novel Hits against
Nyamai DW; Tastan Bishop Ö
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471245
[TBL] [Abstract][Full Text] [Related]
5. Establishing Computational Approaches Towards Identifying Malarial Allosteric Modulators: A Case Study of
Amusengeri A; Astl L; Lobb K; Verkhivker GM; Tastan Bishop Ö
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717270
[TBL] [Abstract][Full Text] [Related]
6. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
Thillainayagam M; Malathi K; Ramaiah S
J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
[TBL] [Abstract][Full Text] [Related]
7. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
Chaudhary M; Singh V; Anvikar AR; Sahi S
Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
[TBL] [Abstract][Full Text] [Related]
8. Peptide Probes for
Saunders CN; Cota E; Baum J; Tate EW
ACS Chem Biol; 2020 Jun; 15(6):1313-1320. PubMed ID: 32383851
[TBL] [Abstract][Full Text] [Related]
9. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Plasmodium falciparum plasmepsin V by ligand-based virtual screening.
Meissner KA; Kronenberger T; Maltarollo VG; Trossini GHG; Wrenger C
Chem Biol Drug Des; 2019 Mar; 93(3):300-312. PubMed ID: 30320974
[TBL] [Abstract][Full Text] [Related]
11. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
[TBL] [Abstract][Full Text] [Related]
12. Computational and biophysical approaches to protein-protein interaction inhibition of Plasmodium falciparum AMA1/RON2 complex.
Pihan E; Delgadillo RF; Tonkin ML; Pugnière M; Lebrun M; Boulanger MJ; Douguet D
J Comput Aided Mol Des; 2015 Jun; 29(6):525-39. PubMed ID: 25822046
[TBL] [Abstract][Full Text] [Related]
13. Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.
Lidumniece E; Withers-Martinez C; Hackett F; Collins CR; Perrin AJ; Koussis K; Bisson C; Blackman MJ; Jirgensons A
Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975947
[TBL] [Abstract][Full Text] [Related]
14. In silico Screening and Evaluation of Plasmodium falciparum Protein Kinase 5 (PK5) Inhibitors.
Eubanks AL; Perkins MM; Sylvester K; Ganley JG; Posfai D; Sanschargrin PC; Hong J; Sliz P; Derbyshire ER
ChemMedChem; 2018 Dec; 13(23):2479-2483. PubMed ID: 30328274
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling, in silico screening and molecular dynamics of PfPRL-PTP of P. falciparum for identification of potential anti-malarials.
Patel S; Joshi D; Soni R; Sharma D; Bhatt TK
J Biomol Struct Dyn; 2016 Jun; 34(6):1330-44. PubMed ID: 26313238
[TBL] [Abstract][Full Text] [Related]
16. In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).
Kumar A; Dhar SK; Subbarao N
J Mol Model; 2018 Aug; 24(9):232. PubMed ID: 30109440
[TBL] [Abstract][Full Text] [Related]
17. Drug target prioritization in Plasmodium falciparum through metabolic network analysis, and inhibitor designing using virtual screening and docking approach.
Yadav MK; Pandey SK; Swati D
J Bioinform Comput Biol; 2013 Aug; 11(4):1350003. PubMed ID: 23859267
[TBL] [Abstract][Full Text] [Related]
18. In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening.
Batool S; Khan ZA; Kamal W; Mushtaq G; Kamal MA
Med Chem; 2015; 11(7):687-700. PubMed ID: 25741881
[TBL] [Abstract][Full Text] [Related]
19. Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target.
Singh J; Vijay S; Mansuri R; Rawal R; Kadian K; Sahoo GC; Kumar M; Sharma A
PLoS One; 2019; 14(8):e0221032. PubMed ID: 31437171
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of plasmodial transketolases and identification of potential inhibitors: an in silico study.
Boateng RA; Tastan Bishop Ö; Musyoka TM
Malar J; 2020 Nov; 19(1):442. PubMed ID: 33256744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
